CME Group Inc. $CME Shares Acquired by Vise Technologies Inc.

Vise Technologies Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 30.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,992 shares of the financial services provider’s stock after purchasing an additional 2,317 shares during the quarter. Vise Technologies Inc.’s holdings in CME Group were worth $2,729,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in CME. Empowered Funds LLC grew its stake in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the period. Marshall Wace LLP grew its stake in shares of CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after purchasing an additional 121,707 shares during the period. Federated Hermes Inc. grew its stake in shares of CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after purchasing an additional 21,918 shares during the period. Nebula Research & Development LLC acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company grew its stake in shares of CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after purchasing an additional 7,397 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Up 0.5%

Shares of NASDAQ:CME opened at $257.40 on Friday. CME Group Inc. has a 1 year low of $244.56 and a 1 year high of $329.16. The firm has a market capitalization of $93.27 billion, a price-to-earnings ratio of 21.96, a price-to-earnings-growth ratio of 2.88 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50 day moving average price is $288.35 and its 200-day moving average price is $288.60.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter last year, the firm posted $2.80 EPS. On average, equities research analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. The Goldman Sachs Group decreased their target price on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. JPMorgan Chase & Co. increased their target price on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. Weiss Ratings reiterated a “buy (a-)” rating on shares of CME Group in a research report on Friday, May 29th. Piper Sandler increased their target price on CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a research report on Wednesday, April 15th. Finally, Morgan Stanley decreased their target price on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $305.29.

Insider Buying and Selling at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. The trade was a 31.39% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 44,044 shares of company stock worth $13,297,507. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.